A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831

Trial Identifier: D6580C00007
Sponsor: AstraZeneca
Collaborator:
Quotient Sciences Limited
NCTID:: NCT04407091
Start Date: June 2020
Primary Completion Date: August 2020
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
United Kingdom Ruddington, United Kingdom, NG11 6JS